13F Holdings
中文EN

VANI Vivani Medical, Inc.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1266806 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-3.9%
TTM EPS YoY26.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-372.2%
ROA-89.6%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets62.6%
Debt / equity0.00x
Current ratio2.40x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.94x
Accruals ratio-5.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY2021*2021-12-31
Income statement
Revenue$0$0——$260,000
Cost of revenue————$130,000
Gross profit————$130,000
R&D expense$18.13M$15.74M$16.97M$14.17M$11.00M
SG&A expense$9.43M$8.93M$10.00M$7.07M$2.32M
Operating income-$27.56M-$24.68M-$26.96M-$21.24M-$13.32M
Pretax income-$26.61M-$23.49M———
Income tax—$2,000———
Net income-$26.61M-$23.49M-$25.65M-$13.89M-$12.77M
EBITDA-$27.13M-$24.28M-$26.61M-$20.86M-$12.98M
EPS (basic)-0.43-0.43-0.50—-0.27
EPS (diluted)-0.43-0.43-0.50—-0.27
Weighted avg. shares (diluted)62.39M54.98M50,853—32.82M
Balance sheet
Cash & equivalents$16.23M$18.35M$20.65M$46.44M$2.18M
Current assets$17.90M$20.44M$23.06M$47.53M$2.47M
PP&E, net$2.88M$1.69M$1.73M$1.18M$1.17M
Total assets$39.39M$41.56M$45.80M$51.13M$5.45M
Current liabilities$6.60M$5.99M$5.72M$6.82M$2.09M
Total liabilities$23.66M$23.95M$25.04M$6.82M$2.99M
Shareholders' equity$15.73M$17.61M$20.76M$44.31M$2.46M
Shares outstanding76.43M59.23M51.03M50,73636.80M
Cash flow statement
Operating cash flow-$24.32M-$20.79M-$23.70M-$18.79M-$10.95M
Capital expenditure$1.17M$556,000$887,000$338,000$572,000
Free cash flow-$25.49M-$21.34M-$24.59M-$19.12M-$11.52M
Investing cash flow-$1.17M-$556,000-$887,000-$338,000-$572,000
Financing cash flow$23.27M$19.05M$133,000$63.39M$11.62M
Depreciation & amortization$424,000$400,000$357,000$381,000$345,000
Stock-based compensation$1.48M$1.61M$1.86M$1.30M$1.67M

Free plan shows the latest 5 periods; Pro shows all 13 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.